UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Radware
RDWR
$1.19B
| $664K | ﹤0.01% |
33,600
-11,568
| -26% | -$242K |
|
|
OLO
2002
DELISTED
Olo Inc
OLO
| $661K | ﹤0.01% |
105,828
+27,517
| +35% | +$208K |
|
|
IMGO
2003
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $661K | ﹤0.01% |
+18,391
| New | +$460K |
|
2004
Koppers
KOP
$969M
| $661K | ﹤0.01% |
23,428
+13,137
| +128% | +$355K |
|
2005
AngioDynamics
ANGO
$649M
| $660K | ﹤0.01% |
47,940
+1,041
| +2% | +$14.5K |
|
2006
Greif Class B
GEF.B
$4.21B
| $658K | ﹤0.01% |
+8,408
| New | +$614K |
|
2007
Consensus Cloud Solutions
CCSI
$647M
| $655K | ﹤0.01% |
12,187
-992
| -8% | -$54.1K |
|
|
TA
2008
DELISTED
TravelCenters of America LLC
TA
| $652K | ﹤0.01% |
14,555
+1,796
| +14% | +$93K |
|
|
OLPX
2009
DELISTED
Olaplex Holdings
OLPX
| $651K | ﹤0.01% |
125,015
-4,977
| -4% | -$29.6K |
|
2010
Ituran Location and Control
ITRN
$1.05B
| $650K | ﹤0.01% |
30,774
| – | – |
|
|
AVDX
2011
DELISTED
AvidXchange
AVDX
| $649K | ﹤0.01% |
65,260
+30,060
| +85% | +$261K |
|
2012
Ichor Holdings
ICHR
$2.56B
| $646K | ﹤0.01% |
24,099
| – | – |
|
2013
Goosehead Insurance
GSHD
$2.32B
| $646K | ﹤0.01% |
18,813
| – | – |
|
2014
Designer Brands
DBI
$333M
| $645K | ﹤0.01% |
65,961
-2,300
| -3% | -$31K |
|
|
CSII
2015
DELISTED
Cardiovascular Systems, Inc.
CSII
| $644K | ﹤0.01% |
47,278
+1,280
| +3% | +$17.8K |
|
2016
Cytek Biosciences
CTKB
$546M
| $644K | ﹤0.01% |
63,032
-6,790
| -10% | -$91.3K |
|
|
PTVE
2017
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $643K | ﹤0.01% |
56,628
+19,902
| +54% | +$217K |
|
2018
Crescent Energy
CRGY
$3.82B
| $642K | ﹤0.01% |
53,580
+17,119
| +47% | +$236K |
|
2019
AerSale
ASLE
$279M
| $641K | ﹤0.01% |
39,520
+3,410
| +9% | +$59.3K |
|
2020
Genco Shipping & Trading
GNK
$1.1B
| $640K | ﹤0.01% |
41,649
+9,382
| +29% | +$136K |
|
2021
BioLife Solutions
BLFS
$1.7B
| $640K | ﹤0.01% |
35,143
| – | – |
|
2022
Mesa Laboratories
MLAB
$574M
| $638K | ﹤0.01% |
3,841
+632
| +20% | +$99K |
|
2023
Liquidity Services
LQDT
$1.32B
| $637K | ﹤0.01% |
45,330
+15,432
| +52% | +$248K |
|
2024
Movado Group
MOV
$841M
| $636K | ﹤0.01% |
19,708
+6,412
| +48% | +$205K |
|
|
CVGW
2025
DELISTED
Calavo Growers
CVGW
| $636K | ﹤0.01% |
21,616
+1,551
| +8% | +$52K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.